Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Rethinking What To Call The ‘Real World’
Jul 22 2019
•
By
Sue Sutter
The US FDA may want to rethink the terminology it uses for real-world studies. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Clinical Trials
More from R&D